Mandate

Vinge has advised Bilia AB in connection with the acquisition of Upplands Motor Stockholm AB, a distributor of Mercedes vehicles

Vinge has advised Bilia AB (publ) ("Bilia") in connection with the acquisition of Upplands Motor Stockholm AB. The acquired company reported a turnover of approximately SEK 1.2 billion and an operating profit of approximately SEK 48 million for 2020. The acquisition was subject to approval from the Swedish Competition Authority.

Upplands Motor Stockholm AB is an authorized distributor for Mercedes that conducts sales and service operations for Mercedes passenger cars, vans and trucks at four facilities in the Stockholm area. Bilia took possession of the acquired company on 1 July 2021. Upplands Motor Stockholm AB has approximately 250 employees.

Vinge's team primarily consisted of Christian Riddarbo, Linus Adolfsson (M&A), Edin Agic (company law), Hampus Olsson (real estate law), Björn Nicolai (EU and competition law), Anna Backman (employment law and EU and competition law) and Alexander Lindeberg (intellectual property law). Magnus Pauli was the responsible partner.

Related

Vinge advises Intera Partners’ portfolio company Yellow Elk in connection with its acquisition of Bizware

Vinge has advised the Nordic private equity firm Intera Partners’ portfolio company Yellow Elk in connection with its acquisition of the data analytics and AI firm Bizware AB and its subsidiaries Bizware Lead AB and Bizware Nova AB.
September 11, 2025

Vinge has acted as local counsel supporting lead counsel Latham & Watkins in advising Cadence in connection with its acquisition of Hexagon’s Design & Engineering Business for approx. EUR 2.7 billion

Cadence (Nasdaq: CDNS) announced it has entered into a definitive agreement to acquire the Design & Engineering business of Hexagon AB, which includes its MSC Software business—a pioneer in engineering simulation and analysis solutions.
September 09, 2025

Vinge has advised Oncopeptides in connection with its rights issue

Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025